Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on ruthenium catalyzed. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel Ru-catalyzed C-H activation method for benzofuran acids. Green oxidant, scalable process for API intermediates and natural products like diptoindonesin G.
Patent CN106749232B details high-yield ruthenium-catalyzed synthesis. Offers supply chain reliability and cost reduction for pharmaceutical intermediate manufacturing globally.
Novel ruthenium-catalyzed route offers high-purity pharmaceutical intermediates with simplified supply chain and cost reduction capabilities.
Patent CN102153434A details a cost-effective ruthenium method for aryl ketones, offering significant supply chain advantages over traditional rhodium processes.
Patent CN112876507B details a Ru-catalyzed hydroarylation method for trisubstituted olefin phosphines, offering high yields up to 90% and reduced costs for pharma intermediates.
Novel ruthenium-catalyzed synthesis of 2-alkyl silicon-benzamide compounds. Reduces steps, eliminates halogenated by-products, ensures high-purity pharmaceutical intermediate supply.
Patent CN107673989B details a ruthenium-catalyzed bromination method offering stable raw materials and simplified processing for high-purity azo intermediate manufacturing supply chains.
Patent CN105399744B reveals optimized Omarigliptin synthesis. High yield and purity benefit supply chain stability and cost reduction significantly.
Novel ruthenium-catalyzed route for Prucalopride intermediate offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing without toxic osmium reagents.
Novel ruthenium-catalyzed method ensures stable C-Si bonds and high yields for silicone acrylic ester manufacturing supply chain optimization.
Patent CN107641098A enables selective pyridone alkenylation using ruthenium catalysis. This method offers high yields and scalable production for pharmaceutical intermediate supply chains.
Patent CN111995636A details a novel Ru-catalyzed hydrosilylation route for ortho-hydroxy-nitrogen silanes, offering high purity and cost-effective manufacturing for pharmaceutical intermediates.
Patent CN112250628B details a green ruthenium-catalyzed hydrogenation method for tetrahydroquinolines, offering mild conditions and high purity for pharmaceutical intermediates.
Novel ruthenium-catalyzed one-pot synthesis reduces steps and cost. High-purity pharmaceutical intermediates with scalable green manufacturing processes for global supply chains.
Novel Ru-catalyzed cascade reaction for anticancer indenopyrazolopyrazolones. Efficient one-pot synthesis offering cost reduction and supply chain reliability for API manufacturers.
Patent CN109651421A details a ruthenium-catalyzed one-pot synthesis for high-purity pharmaceutical intermediates, offering significant cost and supply chain advantages.
Patent CN107089940B enables efficient meta-alkylation. This technology reduces production costs and improves supply chain reliability for high-purity pharmaceutical intermediates globally.
Patent CN110590487A reveals Ru-catalyzed deuteration. Offers high purity and supply chain stability for pharmaceutical intermediates manufacturing and global analysis.
Patent CN107935812B reveals a green ruthenium-catalyzed route for polyaryl naphthalenes, offering significant cost reduction and scalability for optoelectronic and pharmaceutical manufacturing.
Patent CN107522645B details a novel ruthenium-catalyzed [3+2] cycloaddition for polysubstituted pyrroles. This method offers mild conditions and broad substrate scope for pharmaceutical intermediates.